Update: Tandem's Basal IQ Approved
Tandem's Basal-IQ™ technology for their t:slim X2 insulin pump received Health Canada's approval. This feature will allow for predictive low glucose suspend (PLGS) to help reduce the frequency and duration of hypoglycemia. For more information read: The news release and Tandem's website.
- This feature will only work with Dexcom G6 glucose sensors
- The completion of an online training module is required by the patient prior to updating software
- All in-warranty users will have the option to upgrade free using a computer
- The software update is expected to be available in February 2020
Update: SGLT-2s and eGFR
We are awaiting updates to Diabetes Canada guidelines. We anticipate them to include news about SGLT-2 and renal disease. In the mean time, we added the newest monograph indications regarding SGLT-2 and eGFR to Diabetes Canada's Therapeutic Considerations for Renal Impairment. Here is the direct link
This version of the document is found on our Topics Catalogue page under:Renal Disease (Chronic Kidney Disease - CKD)
Update: Educator Rounds - Nov 27, 0800 - 0915
Our next Educator Rounds is Wednesday, Nov 27th from 0800-0915. The focus will be on dietary guidelines for people with chronic kidney disease. We are fortunate to welcome Stephanie Jackson, Team Lead with Chronic Disease Management to lead us through the guidelines. Join via Skype, or phone 587-952-0425 (conference ID: 39326727)